Most Recent

image: Messages in the Noise

Messages in the Noise

By | August 1, 2015

After spending more than a decade developing tools to study patterns in gene sequences, bioinformaticians are now working on programs to analyze epigenomics data.

0 Comments

image: Getting Your Sugar Fix

Getting Your Sugar Fix

By | April 1, 2015

A guide to glycan microarrays

1 Comment

image: Nuclear Cartography

Nuclear Cartography

By | October 1, 2014

Techniques for mapping chromosome conformation

0 Comments

image: Entry Requirements

Entry Requirements

By | September 1, 2014

Recent developments in cell transfection and molecular delivery technologies

0 Comments

image: Hear Ye, Hear Ye

Hear Ye, Hear Ye

By | May 1, 2014

Tools for tracking quorum-sensing signals in bacterial colonies

2 Comments

image: Beauty, Science-Deep

Beauty, Science-Deep

By | September 1, 2013

Cosmetics companies use advanced genomics and in vitro technology to make skin look young and vibrant—you may never view the makeup aisle the same way again.

1 Comment

image: Gene Silencing Is Golden

Gene Silencing Is Golden

By | August 1, 2013

A beginner’s how-to on RNAi screening in mammalian cells

0 Comments

image: Pluripotent Until Needed

Pluripotent Until Needed

By | April 1, 2013

Microarrays help keep induced pluripotent stem cell lines in check, from start to finish.

0 Comments

image: Buying Cell-Culture Products

Buying Cell-Culture Products

By | March 1, 2013

A survey of The Scientist readers reveals who buys cell-growth products from whom, and why.

0 Comments

image: Set It and Forget It

Set It and Forget It

By | March 1, 2013

A tour of three systems for automating cell culture

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech